by Cassie Arnold | Feb 25, 2020 | Biotech Finance, Digital Health, Digital Therapeutic
When I started following the digital health sector in earnest about ten years ago, I was intrigued with the potential of digital technology to treat disease – the so-called digital therapeutics. Instead, the sector produced an almost infinite variety of activity...
by Cassie Arnold | Mar 10, 2017 | Biotech Finance
Recently the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group representing the US pharmaceutical industry, launched an unprecedented image campaign titled “Go Boldly.” The campaign was rolled out amid puzzled looks from biopharmaceutical...
by Cassie Arnold | Jan 30, 2017 | Biotech Finance
I’m breaking with tradition and publishing my own predictions for the life sciences sector in 2017. I do research like this all the time for clients, but I never put it out under my own name. I’m taking the plunge this year because with the regime change in Washington...
